• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Adaptimmune Therapeutics Opens Headquarters-Manufacturing Expansion In Philadelphia, Pennsylvania

Adaptimmune Therapeutics, a clinical stage biopharmaceutical company, opened its new headquarters and manufacturing plant expansion, committing to the creation of 110 jobs in Philadelphia, Pennsylvania.

The ribbon cutting marks the opening of Adaptimmune’s newly constructed, 47,400-square-foot United States headquarters and base for clinical and manufacturing operations at the Philadelphia Navy Yard. The company invested more than $4 million in the project and committed to the creation of 110 new, full-time jobs and the retention of 14 existing positions over within three years.

“We are pleased to officially open our U.S. headquarters featuring what will be our new state-of-the-art cGMP manufacturing facility, designed to support the clinical development and initial commercialization of our novel immunotherapies,” said Adaptimmune CEO James Noble.

“We appreciate the support provided by the DCED and the Governor’s Action Team during this process, and are confident that this location provides us with an environment that promotes strong business growth and innovation as well as access to a deep pool of scientific talent from the region,” he added.

“It’s an honor to participate in Adaptimmune’s ribbon cutting event today for the company’s new headquarters and manufacturing expansion and commitment of 110 new, high-paying, full-time jobs at the Philadelphia Navy Yard,” said Economic Development Secretary Dennis Davin. “Governor Wolf is committed to providing the resources needed to create new jobs, as well as support and retain existing jobs through workforce training and investment that will continue to grow our economy in every community throughout the state.”

Exclusive Research